- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Total meningococcal vaccination market size in China 2017-2030
Premium statistics
Industry-specific and extensively researched technical data (partially from exclusive partnerships).
A paid subscription is required for full access.
Total meningococcal vaccination market size in China 2017-2030
Meningococcal vaccine market size in China from 2017 to 2030, based on sales revenue (in billion yuan)
by Statista Research Department,
last edited
Mar 8, 2019
This statistic shows the total meningococcal vaccine market size in China in 2017 with projections until 2030. By 2030, China's meningococcal vaccination market size was forecasted to grow up to 6.91 billion yuan in total.
Meningococcal vaccine market size in China from 2017 to 2030, based on sales revenue (in billion yuan)
| Market size in billion yuan | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| Market size in billion yuan | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
Exclusive content
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Chart type
Datalabels
Share on Social Media
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
by Statista Research Department,
last edited
Mar 8, 2019
This statistic shows the total meningococcal vaccine market size in China in 2017 with projections until 2030. By 2030, China's meningococcal vaccination market size was forecasted to grow up to 6.91 billion yuan in total.
- Show sources information
- Show publisher information
- Release date
- February 2019
- Region
- China
- Survey time period
- 2017
- Supplementary notes
-
*Forecast.
Note: 1 yuan equals approximately 0.15 U.S. dollars and 0.13 euros (as of March 2019).
Figures have been rounded.
Source
- Show sources information
- Show publisher information
- Release date
- February 2019
More information
- Region
- China
- Survey time period
- 2017
- Supplementary notes
-
*Forecast.
Note: 1 yuan equals approximately 0.15 U.S. dollars and 0.13 euros (as of March 2019).
Figures have been rounded.
Other statistics on the topic
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation
Statistics on "Vaccine hesitancy in the U.S."
- Overview
The most important statistics
- Number of new cases of mumps in the U.S. from 1970 to 2016New cases of mumps in the U.S. 1970-2016
- New cases of mumps per 100,000 population in the U.S. from 1970 to 2016New cases of mumps in the U.S. 1970-2016
- Number of new cases of measles (rubeola) in the U.S. from 1950 to 2019New cases of measles in the U.S. 1950-2019
- New cases of measles (rubeola) per 100,000 population in the U.S. from 1950 to 2016New cases of measles in the U.S. 1950-2016
- Percentage of U.S. adults that had heard of various infectious diseases as of 2017U.S. adults with knowledge of infectious diseases as of 2017
- Percentage of U.S. adults that had heard of various infectious diseases as of 2017, by genderU.S. adults with knowledge of infectious diseases as of 2017, by gender
- Percentage of U.S. adults that had heard of various infectious diseases as of 2017, by ageU.S. adults with knowledge of infectious diseases as of 2017, by age
- Vaccinations among children
The most important statistics
- Percentage of U.S. children aged 19-35 months who received all doses of recommended vaccines in 2017Share of U.S. children who received all doses of recommended vaccines 2017
- Percentage of children aged 19-35 months who are vaccinated against measles, mumps and rubella (MMR) in the U.S. from 1994 to 2017MMR vaccination rate among U.S. children aged 19-35 months 1994-2017
- Percentage of children in the U.S. who had completed the CDC-recommended seven-vaccine series from 2010 to 2013Share of U.S. children who had received all CDC-recommended vaccines from 2010-2013
- Percentage of children in the U.S. who had completed select vaccine regiments in 2010 and 2013Share of U.S. children who had completed select vaccine regiments in 2010 and 2013
- Reasons for hesitancy
The most important statistics
- Most common reasons given to U.S. health care professionals by families for refusing vaccines or requesting alternative schedules as of 2016Reasons U.S. families gave health care professionals for refusing vaccinations 2016
- Percentage of U.S. adults that had select reasons for not getting the flu vaccine during the last flu season as of 2018Adults' reasons for not getting the flu vaccine in the U.S. as of 2018
- Percentage of U.S. college students who gave the following reasons for not getting a flu vaccine as of 2017Reasons for not receiving a flu vaccine among U.S. university students as of 2017
- Distribution of reasons for under-vaccination among children scheduled to complete the CDC-recommended seven vaccine series by 2016Share of reasons for under-vaccination among U.S. children as of 2016
- Refusals and exemptions
The most important statistics
- Vaccines health care professionals said families were most likely to refuse or request on an alternative schedule in the U.S. as of 2016Vaccines families were most likely to refuse in the U.S. 2016
- Number of religious and philosophical exemptions for vaccines among kindergarteners in the U.S. in the 2017-2018 school year, by stateReligious and philosophical exemptions to vaccinations in the U.S. in 2018, by state
- Percentage of U.S. kindergarteners who received vaccination exemptions in the 2017-2018 school year, by statePercentage of kindergarteners with vaccine exemptions in the U.S. in 2018, by state
- Percentage of infants with at least one parental vaccination refusal in the U.S. from 2010 to 2016, by state*Share of U.S. infants with a parental vaccination refusal 2010-2016, by state
- Injury and death from vaccinations
The most important statistics
- Number of petitions filed per year seeking compensation for injury or death caused by vaccines in the U.S. from 1988 to 2019Number of petitions filed per year for damages caused by vaccines U.S. 1988-2019
- Number of petitions filed seeking compensation for injury or death caused by select vaccines in the U.S. between 1988 and 2019*Number of petitions filed for injury or death caused by vaccines U.S. 1988-2019
- Number of petitions filed seeking compensation for injury or death caused by select vaccines in the U.S. between 1988 and 2019, by outcome*Number of petitions filed for damages caused by vaccines U.S. 1988-2019, by outcome
- Public opinion
The most important statistics
- Percentage of U.S. adults that had select opinions on the importance of parents vaccinating their children as of 2018Opinions on the importance of childhood vaccinations in the U.S. as of 2018
- Percentage of U.S. adults that felt it was important for parents to vaccinate their children in 2008 and 2018Opinions on the importance of childhood vaccinations in the U.S. 2008 vs. 2018
- Percentage of U.S. adults that believed vaccines were important to the health of society as of 2018U.S. adult thoughts on the importance of vaccines to societal health as of 2018
- Percentage of U.S. adults that believed vaccines were important to the health of society in 2008 and 2018U.S. adults that believed vaccines were important for societal health 2008 and 2018
- Percentage of U.S. adults that believed when one child is not vaccinated it puts other children at risk as of 2018Opinions on risk from unvaccinated children in the U.S. as of 2018
- Percentage of U.S. adults that believed they had personally benefitted from the development of vaccines over the past 50 years in 2008 and 2018U.S. adults who felt they benefited from vaccines as of 2008 and 2018
- Percentage of adults in the U.S. who thought the benefits of the measles, mumps and rubella vaccine outweighed the risks as of 2016, by ageShare of U.S. adults who felt MMR vaccine benefits outweigh risks 2016, by age
- Percentage of adults in the U.S. who supported school-based measles, mumps and rubella vaccine requirements as of 2016, by ageShare of U.S. adults who supported MMR vaccine school requirements 2016, by age
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Total lot release volume of meningococcal vaccinations in China 2017-2030
- Total lot release volume of private meningococcal vaccinations in China 2017-2030
- Total lot release volume of public meningococcal vaccinations in China 2017-2030
- Total lot release volume of public DTP vaccinations in China 2017-2030
- Pneumococcal polysaccharide vaccination market size in China 2017-2030
- Total DTaP vaccination market size in China 2017-2030
- Total DTP vaccination market size in China 2017-2030
- Total lot release volume of pneumococcal vaccinations in China 2017-2030
- Total lot release volume of private DTP vaccinations in China 2017-2030
- Total pneumococcal vaccination market size in China 2017-2030
- Total lot release volume of DTP vaccinations in China 2017-2030
- Total DTcP and combined vaccination market size in China 2017-2030
- Pneumococcal conjugate vaccination market size in China 2017-2030
- Total lot release volume of vaccinations in China 2013-2030
- Global vaccine market share by administration route 2028 forecast
- Meningococcal group C immunisation in England 2003-13
- Basic vaccines: revenues in selected countries 2013
- India: vaccine market value by segment 2012
- Size of the U.S. vaccine market by age 2014-2024
- Size of the total U.S. vaccine market 2014-2024
Studies
- Vaccine hesitancy in the U.S.
- Vaccinations in the U.S.
- Vaccinations in Canada
- Vaccinations in Italy
- Transforming India's Vaccine Market
- Vaccine industry in China
- Sanofi
- PhRMA - Vaccine Fact Book 2013
- Zoetis Annual Report 2018
- Zoetis
- Market Insight Animal Health
- Childhood Immunisation Statistics, Scotland 2016
- Childhood Immunisation Statistics, Scotland 2014
- Childhood Immunisation Statistics, Scotland 2015
- GlaxoSmithKline - Annual Report 2018
Statistics on "Vaccine hesitancy in the U.S."
- Number of new cases of mumps in the U.S. from 1970 to 2016
- New cases of mumps per 100,000 population in the U.S. from 1970 to 2016
- Number of new cases of measles (rubeola) in the U.S. from 1950 to 2019
- New cases of measles (rubeola) per 100,000 population in the U.S. from 1950 to 2016
- Percentage of U.S. adults that had heard of various infectious diseases as of 2017
- Percentage of U.S. adults that had heard of various infectious diseases as of 2017, by gender
- Percentage of U.S. adults that had heard of various infectious diseases as of 2017, by age
- Percentage of U.S. children aged 19-35 months who received all doses of recommended vaccines in 2017
- Percentage of children aged 19-35 months who are vaccinated against measles, mumps and rubella (MMR) in the U.S. from 1994 to 2017
- Percentage of children in the U.S. who had completed the CDC-recommended seven-vaccine series from 2010 to 2013
- Percentage of children in the U.S. who had completed select vaccine regiments in 2010 and 2013
- Most common reasons given to U.S. health care professionals by families for refusing vaccines or requesting alternative schedules as of 2016
- Percentage of U.S. adults that had select reasons for not getting the flu vaccine during the last flu season as of 2018
- Percentage of U.S. college students who gave the following reasons for not getting a flu vaccine as of 2017
- Distribution of reasons for under-vaccination among children scheduled to complete the CDC-recommended seven vaccine series by 2016
- Vaccines health care professionals said families were most likely to refuse or request on an alternative schedule in the U.S. as of 2016
- Number of religious and philosophical exemptions for vaccines among kindergarteners in the U.S. in the 2017-2018 school year, by state
- Percentage of U.S. kindergarteners who received vaccination exemptions in the 2017-2018 school year, by state
- Percentage of infants with at least one parental vaccination refusal in the U.S. from 2010 to 2016, by state*
- Number of petitions filed per year seeking compensation for injury or death caused by vaccines in the U.S. from 1988 to 2019
- Number of petitions filed seeking compensation for injury or death caused by select vaccines in the U.S. between 1988 and 2019*
- Number of petitions filed seeking compensation for injury or death caused by select vaccines in the U.S. between 1988 and 2019, by outcome*
- Percentage of U.S. adults that had select opinions on the importance of parents vaccinating their children as of 2018
- Percentage of U.S. adults that felt it was important for parents to vaccinate their children in 2008 and 2018
- Percentage of U.S. adults that believed vaccines were important to the health of society as of 2018
- Percentage of U.S. adults that believed vaccines were important to the health of society in 2008 and 2018
- Percentage of U.S. adults that believed when one child is not vaccinated it puts other children at risk as of 2018
- Percentage of U.S. adults that believed they had personally benefitted from the development of vaccines over the past 50 years in 2008 and 2018
- Percentage of adults in the U.S. who thought the benefits of the measles, mumps and rubella vaccine outweighed the risks as of 2016, by age
- Percentage of adults in the U.S. who supported school-based measles, mumps and rubella vaccine requirements as of 2016, by age
- Percentage of adults in the U.S. who cared a great deal about issues related to childhood measles, mumps and rubella vaccines as of 2016, by gender
- Meningococcal vaccine lot release volume in China from 2017 to 2030 (in million doses)
- Meningococcal vaccine lot release volume for private market in China from 2017 to 2030 (in million doses)
- Meningococcal vaccine lot release volume for public market in China from 2017 to 2030 (in million doses)
- DTP (diphtheria/tetanus/pertussis) vaccine lot release volume for public market in China from 2017 to 2030 (in million doses)
- Pneumococcal polysaccharide vaccine (PPV23) market size in China from 2017 to 2030, based on sales revenue (in billion yuan)
- DTaP (diphtheria/tetanus/pertussis) vaccine market size in China from 2017 to 2030, based on sales revenue (in million yuan)
- DTP (diphtheria/tetanus/pertussis) vaccine market size in China from 2017 to 2030, based on sales revenue (in billion yuan)
- Pneumococcal vaccine lot release volume for private market in China from 2017 to 2030 (in million doses)
- DTP (diphtheria/tetanus/pertussis) vaccine lot release volume for private market in China from 2017 to 2030 (in million doses)
- Pneumococcal vaccine market size in China from 2017 to 2030, based on sales revenue (in billion yuan)
- DTP (diphtheria/tetanus/pertussis) vaccine lot release volume in China from 2017 to 2030 (in million doses)
- DTcP and combined vaccine (DTaP-Hib and DTcP-Hib-Polio) market size in China from 2017 to 2030, based on sales revenue (in billion yuan)
- Pneumococcal conjugate vaccine (PCV13) market size in China from 2017 to 2030, based on sales revenue (in billion yuan)
- Vaccine lot release volume in China from 2013 to 2030 (in million doses)
- Percentage of the global vaccine market in 2017 and a forecast for 2028, by route of administration
- Proportion of children immunized against meningococcal group C in England from 2003 to 2013
- Vaccine market revenues in selected countries as of 2013 (in billion U.S. dollars)
- Indian vaccine market value in 2012, by segment (in million U.S. dollars)
- Vaccine market size in the U.S. from 2014 to 2024, by age group (in billion U.S. dollars)
- Total vaccine market size in the U.S. from 2014 to 2024 (in billion U.S. dollars)
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Save statistic in .XLS format
You can only download this statistic as a Premium user.
Save statistic in .PNG format
You can only download this statistic as a Premium user.
Save statistic in .PDF format
You can only download this statistic as a Premium user.
Show source references
As a Premium user you get access to the detailed source references and background information about this statistic.
Show details about this statistic
As a Premium user you get access to background information and details about the release of this statistic.
Bookmark statistics
As soon as this statistic is updated, you will immediately be notified via e-mail.
Change statistics options
You need at least a Premium Account to use this feature.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.